{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:09:17Z","timestamp":1794647357368,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabet Med"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>People with diabetes receiving haemodialysis are at increased risk of diabetic retinopathy (DR) and other ocular complications. Despite this heightened vulnerability, evidence on the prevalence of such conditions in this population is limited.\u00a0 This review aimed to synthesise the existing literature on the prevalence of DR and other ocular conditions, and to evaluate screening rates in people with diabetes undergoing haemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of MEDLINE, EMBASE and CINAHL databases was conducted to identify studies reporting on the prevalence of DR, diabetic maculopathy and other ocular conditions in people with diabetes on haemodialysis. Eight articles meeting inclusion criteria were included. Pooled prevalence estimates and 95% confidence intervals (CIs) were calculated using random\u2010effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pooled prevalence of DR was 49.1% (95% CI: 23.1\u201375.4), while diabetic maculopathy prevalence was 32.5% (95% CI: 10.9\u201359.1). Other ocular complications reported included cataracts (53.4%), conjunctival calcification (63%) and corneal calcification (45.3%). Notably, 54.3% (95% CI: 35.4\u201372.6) of individuals on haemodialysis had not undergone eye screening in over two years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review reveals a high prevalence of DR and other ocular complications in people with diabetes undergoing haemodialysis, alongside significant under\u2010screening. Future research should focus on developing and accessing targeted interventions to improve screening uptake in this vulnerable population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dme.70157","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T07:55:51Z","timestamp":1759823751000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetic eye screening in people with diabetes undergoing haemodialysis: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"42","author":[{"given":"Hellena Hailu","family":"Habte\u2010Asres","sequence":"first","affiliation":[{"name":"Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care King's College London  London UK"},{"name":"Royal Free London NHS Foundation Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frehiwot","family":"Hailu","sequence":"additional","affiliation":[{"name":"Colorado Technical University  Colorado Springs Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3331-755X","authenticated-orcid":false,"given":"Angus","family":"Forbes","sequence":"additional","affiliation":[{"name":"Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0745-3478","authenticated-orcid":false,"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"UCL Department of Nephrology University College London, Royal Free Campus  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-0381","authenticated-orcid":false,"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[{"name":"Centre for Public Health Queen's University Belfast  Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1909"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2011.02599.x"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-017-0974-1"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70998-9"},{"issue":"8","key":"e_1_2_12_6_1","first-page":"410","article-title":"Diabetic microvasculopathy: the renal\u2010retinal link","volume":"102","author":"Banerjee S","year":"2004","journal-title":"J Indian Med Assoc"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.130"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0003752022"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1292412"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03612-5"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15010157"},{"key":"e_1_2_12_12_1","volume-title":"Management of adults with diabetes on dialysis","author":"JBDS","year":"2023"},{"key":"e_1_2_12_13_1","unstructured":"National Heart L. and Blood Institute.Quality assessment tool for observational cohort and cross\u2010sectional studies. n.d. Available from: file:\/\/\/C:\/Users\/K1802349\/Downloads\/Quality\u2010Assessment\u2010Tool\u2010for\u2010Observational\u2010Cohort\u2010and\u2010Cross\u2010Sectional\u2010Studies\u2010NHLBI\u2010NIH3%20(1).pdf."},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.12"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1044"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0001802022"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.13510"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2023-003373"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0007082020"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_464_18"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2021.827718"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.684675"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2024.08.005"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/aos.15788"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apjo.2024.100071"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2021.827718"},{"key":"e_1_2_12_27_1","unstructured":"NICE.Type 1 diabetes in adults: diagnosis and management.2022."},{"key":"e_1_2_12_28_1","volume-title":"Type 2 Diabetes in Adults: Management","author":"NICE","year":"2022"},{"issue":"1","key":"e_1_2_12_29_1","first-page":"S6","article-title":"Summary of revisions: standards of Care in Diabetes\u20142025","volume":"48","author":"Committee, A.D.A.P.P","year":"2024","journal-title":"Diabetes Care"},{"key":"e_1_2_12_30_1","volume-title":"Diabetic Retinopathy Screening: A Short Guide: Increase Effectiveness, Maximize Benefits and Minimize Harm 2021","author":"Organization., W.H., Regional Office for Europe","year":"2020"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.15381"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10823"},{"key":"e_1_2_12_33_1","unstructured":"NHS\u2010England.NHS Long Term Plan.2019."}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/dme.70157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:11:19Z","timestamp":1763565079000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/dme.70157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1111\/dme.70157"],"URL":"https:\/\/doi.org\/10.1111\/dme.70157","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"2025-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70157"}}